203 related articles for article (PubMed ID: 37713508)
1. Integrated BATF transcriptional network regulates suppressive intratumoral regulatory T cells.
Shan F; Cillo AR; Cardello C; Yuan DY; Kunning SR; Cui J; Lampenfeld C; Williams AM; McDonough AP; Pennathur A; Luketich JD; Kirkwood JM; Ferris RL; Bruno TC; Workman CJ; Benos PV; Vignali DAA
Sci Immunol; 2023 Sep; 8(87):eadf6717. PubMed ID: 37713508
[TBL] [Abstract][Full Text] [Related]
2. Novel Effector Phenotype of Tim-3
Liu Z; McMichael EL; Shayan G; Li J; Chen K; Srivastava R; Kane LP; Lu B; Ferris RL
Clin Cancer Res; 2018 Sep; 24(18):4529-4538. PubMed ID: 29712685
[No Abstract] [Full Text] [Related]
3. BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors.
Itahashi K; Irie T; Yuda J; Kumagai S; Tanegashima T; Lin YT; Watanabe S; Goto Y; Suzuki J; Aokage K; Tsuboi M; Minami Y; Ishii G; Ohe Y; Ise W; Kurosaki T; Suzuki Y; Koyama S; Nishikawa H
Sci Immunol; 2022 Oct; 7(76):eabk0957. PubMed ID: 36206353
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer.
Chuckran CA; Cillo AR; Moskovitz J; Overacre-Delgoffe A; Somasundaram AS; Shan F; Magnon GC; Kunning SR; Abecassis I; Zureikat AH; Luketich J; Pennathur A; Sembrat J; Rojas M; Merrick DT; Taylor SE; Orr B; Modugno F; Buckanovich R; Schoen RE; Kim S; Duvvuri U; Zeh H; Edwards R; Kirkwood JM; Coffman L; Ferris RL; Bruno TC; Vignali DAA
Sci Transl Med; 2021 Dec; 13(623):eabf8495. PubMed ID: 34878821
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy.
Miraki Feriz A; Bahraini F; Khosrojerdi A; Azarkar S; Sajjadi SM; HosseiniGol E; Honardoost MA; Saghafi S; Silvestris N; Leone P; Safarpour H; Racanelli V
PLoS One; 2023; 18(12):e0295863. PubMed ID: 38096229
[TBL] [Abstract][Full Text] [Related]
6. Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer.
Gadwa J; Bickett TE; Darragh LB; Knitz MW; Bhatia S; Piper M; Van Court B; Bhuvane S; Nguyen D; Nangia V; Kleczko EK; Nemenoff RA; Karam SD
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33789881
[TBL] [Abstract][Full Text] [Related]
7. CD45RA-Foxp3high but not CD45RA+Foxp3low suppressive T regulatory cells increased in the peripheral circulation of patients with head and neck squamous cell carcinoma and correlated with tumor progression.
Sun W; Li WJ; Wu CY; Zhong H; Wen WP
J Exp Clin Cancer Res; 2014 Apr; 33(1):35. PubMed ID: 24761979
[TBL] [Abstract][Full Text] [Related]
8. Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.
Knitz MW; Bickett TE; Darragh LB; Oweida AJ; Bhatia S; Van Court B; Bhuvane S; Piper M; Gadwa J; Mueller AC; Nguyen D; Nangia V; Osborne DG; Bai X; Ferrara SE; Boss MK; Goodspeed A; Burchill MA; Tamburini BAJ; Chan ED; Pickering CR; Clambey ET; Karam SD
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33883256
[TBL] [Abstract][Full Text] [Related]
9. BATF is Required for Treg Homeostasis and Stability to Prevent Autoimmune Pathology.
Khatun A; Wu X; Qi F; Gai K; Kharel A; Kudek MR; Fraser L; Ceicko A; Kasmani MY; Majnik A; Burns R; Chen YG; Salzman N; Taparowsky EJ; Fang D; Williams CB; Cui W
Adv Sci (Weinh); 2023 Oct; 10(28):e2206692. PubMed ID: 37587835
[TBL] [Abstract][Full Text] [Related]
10. Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis.
Wen YH; Lin HQ; Li H; Zhao Y; Lui VWY; Chen L; Wu XM; Sun W; Wen WP
Cancer Immunol Immunother; 2019 Feb; 68(2):221-232. PubMed ID: 30357458
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients.
Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Cai XY; He HW; Jin JJ; Cheng YF; Fan J; Sun J; Qiu SJ
J Gastroenterol Hepatol; 2013 Sep; 28(9):1555-64. PubMed ID: 23517245
[TBL] [Abstract][Full Text] [Related]
12. CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy.
Jeon SH; Kang M; Jeon M; Chung Y; Kim AR; Lee YJ; Kim ES; Nam H; Park J; Lee JY; Shin EC; Seo SI; Park SH
Clin Cancer Res; 2023 May; 29(9):1794-1806. PubMed ID: 36716293
[TBL] [Abstract][Full Text] [Related]
13. CD45RA
Ihara F; Sakurai D; Horinaka A; Makita Y; Fujikawa A; Sakurai T; Yamasaki K; Kunii N; Motohashi S; Nakayama T; Okamoto Y
Cancer Immunol Immunother; 2017 Oct; 66(10):1275-1285. PubMed ID: 28551813
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy.
Rutihinda C; Haroun R; Saidi NE; Ordoñez JP; Naasri S; Lévesque D; Boisvert FM; Fortier PH; Belzile M; Fradet L; Hubert-Tremblay V; Turgeon GA; Wang CS; Delage P; Rousseau É; Paquette B; Oweida AJ
Cancer Immunol Immunother; 2023 May; 72(5):1089-1102. PubMed ID: 36326893
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells induce CD4
Ihara F; Sakurai D; Takami M; Kamata T; Kunii N; Yamasaki K; Iinuma T; Nakayama T; Motohashi S; Okamoto Y
Cancer Immunol Immunother; 2019 Dec; 68(12):1935-1947. PubMed ID: 31641795
[TBL] [Abstract][Full Text] [Related]
17. Highly immunosuppressive HLADR
Yang H; Ye S; Goswami S; Li T; Wu J; Cao C; Ma J; Lu B; Pei X; Chen Y; Yu J; Xu H; Qiu L; Afridi S; Xiang L; Zhang X
Int J Cancer; 2020 Apr; 146(7):1993-2006. PubMed ID: 31709528
[TBL] [Abstract][Full Text] [Related]
18. Functionally distinct subsets of CD4⁺ regulatory T cells in patients with laryngeal squamous cell carcinoma are indicative of immune deregulation and disease progression.
Sun W; Li WJ; Fu QL; Wu CY; Lin JZ; Zhu XL; Hou WJ; Wei Y; Wen YH; Wang YJ; Wen WP
Oncol Rep; 2015 Jan; 33(1):354-62. PubMed ID: 25333227
[TBL] [Abstract][Full Text] [Related]
19. MondoA-Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identity and Function in Colorectal Cancer Microenvironment.
Lu Y; Li Y; Liu Q; Tian N; Du P; Zhu F; Han Y; Liu X; Liu X; Peng X; Wang X; Wu Y; Tong L; Li Y; Zhu Y; Wu L; Zhang P; Xu Y; Chen H; Li B; Tong X
Gastroenterology; 2021 Aug; 161(2):575-591.e16. PubMed ID: 33901495
[TBL] [Abstract][Full Text] [Related]
20. JunB Controls Intestinal Effector Programs in Regulatory T Cells.
Wheaton JD; Ciofani M
Front Immunol; 2020; 11():444. PubMed ID: 32296416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
